keyword
https://read.qxmd.com/read/38641026/neonatal-brain-inflammation-enhances-methamphetamine-induced-reinstated-behavioral-sensitization-in-adult-rats-analyzed-with-explainable-machine-learning
#1
JOURNAL ARTICLE
Kuo-Ching Wang, Norma B Ojeda, Haifeng Wang, Han-Sun Chiang, Michelle A Tucci, Jonathan W Lee, Han-Chi Wei, Asuka Kaizaki-Mitsumoto, Sachiko Tanaka, Nilesh Dankhara, Lu-Tai Tien, Lir-Wan Fan
Neonatal brain inflammation produced by intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) results in long-lasting brain dopaminergic injury and motor disturbances in adult rats. The goal of the present work is to investigate the effect of neonatal systemic LPS exposure (1 or 2 mg/kg, i.p. injection in postnatal day 5, P5, male rats)-induced dopaminergic injury to examine methamphetamine (METH)-induced behavioral sensitization as an indicator of drug addiction. On P70, subjects underwent a treatment schedule of 5 once daily subcutaneous (s...
April 17, 2024: Neurochemistry International
https://read.qxmd.com/read/38640863/co-administration-of-naloxone-and-dexmedetomidine-to-simultaneously-reverse-acute-effects-of-fentanyl-and-methamphetamine-in-rats
#2
JOURNAL ARTICLE
Wesley R Tackett, Jyostna Yalakala, Michael D Hambuchen
BACKGROUND: The incidence of combination methamphetamine (METH)-opioid overdose has substantially increased in recent years. While agitation is uncommon after the naloxone (NLX) reversal of opioids, it is a major clinical concern in acute METH intoxication and can be physiologically antagonized by opioid-induced sedation. This study aimed to perform initial preclinical analysis of the safety and efficacy of dexmedetomidine (DEXMED) co-administered with NLX to attenuate METH-induced locomotor activity, as a rat model of agitation, after the reversal of fentanyl (FENT)-induced sedation...
April 16, 2024: Drug and Alcohol Dependence
https://read.qxmd.com/read/38622130/high-frequency-deep-brain-stimulation-of-the-dorsal-raphe-nucleus-prevents-methamphetamine-priming-induced-reinstatement-of-drug-seeking-in-rats
#3
JOURNAL ARTICLE
Libo Zhang, Shiqiu Meng, Enze Huang, Tianqi Di, Zengbo Ding, Shihao Huang, Wenjun Chen, Jiayi Zhang, Shenghong Zhao, Ting Yuwen, Yang Chen, Yanxue Xue, Feng Wang, Jie Shi, Yu Shi
Drug addiction represents a multifaceted and recurrent brain disorder that possesses the capability to create persistent and ineradicable pathological memory. Deep brain stimulation (DBS) has shown a therapeutic potential for neuropsychological disorders, while the precise stimulation targets and therapeutic parameters for addiction remain deficient. Among the crucial brain regions implicated in drug addiction, the dorsal raphe nucleus (DRN) has been found to exert an essential role in the manifestation of addiction memory...
April 15, 2024: Translational Psychiatry
https://read.qxmd.com/read/38612400/methamphetamine-enhancement-of-hiv-1-gp120-mediated-nlrp3-inflammasome-activation-and-resultant-proinflammatory-responses-in-rat-microglial-cultures
#4
JOURNAL ARTICLE
Debashis Dutta, Jianuo Liu, Enquan Xu, Huangui Xiong
Human Immunodeficiency Virus type 1 (HIV-1)-associated neurocognitive disorders (HANDs) remain prevalent in HIV-1-infected individuals despite the evident success of combined antiretroviral therapy (cART). The mechanisms underlying HAND prevalence in the cART era remain perplexing. Ample evidence indicates that HIV-1 envelope glycoprotein protein 120 (gp120), a potent neurotoxin, plays a pivotal role in HAND pathogenesis. Methamphetamine (Meth) abuse exacerbates HANDs, but how this occurs is not fully understood...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38587377/dextromethorphan-moderates-reward-deficiency-associated-with-central-serotonin-transporter-availability-in-3-4-methylenedioxy-methamphetamine-treated-animals
#5
JOURNAL ARTICLE
Chuang-Hsin Chiu, Kuo-Hsing Ma, Eagle Yi-Kung Huang, Hsien-Wen Chang, Shao-Ju Weng, Tsung-Hsun Yu, Shiou-Shiow Farn, Yu-Yeh Kuo, Wen-Sheng Huang, Cheng-Yi Cheng, Pao-Luh Tao, Skye Hsin-Hsien Yeh
BACKGROUND: The neurotoxicity of 3,4-methylenedioxy-methamphetamine (MDMA) to the serotonergic system is well-documented. Dextromethorphan (DM), an antitussive drug, decreased morphine- or methamphetamine (MA)-induced reward in rats and may prevent MDMA-induced serotonergic deficiency in primates, as indicated by increased serotonin transporter (SERT) availability. We aimed to investigate the effects of DM on reward, behavioral sensitization, and neurotoxicity associated with loss of SERT induced by chronic MDMA administration in rats...
April 8, 2024: Journal of the Chinese Medical Association: JCMA
https://read.qxmd.com/read/38580165/vesicular-monoamine-transporter-2-inhibitor-jpc-141-prevents-methamphetamine-induced-dopamine-toxicity-and-blocks-methamphetamine-self-administration-in-rats
#6
JOURNAL ARTICLE
Cassie M Chandler, Justin R Nickell, A George Wilson, John P Culver, Peter A Crooks, Michael T Bardo, Linda P Dwoskin
Previous research has demonstrated therapeutic potential for VMAT2 inhibitors in rat models of methamphetamine use disorder. Here, we report on the neurochemical and behavioral effects of 1-(2-methoxyphenethyl)-4-phenethypiperazine (JPC-141), a novel analog of lobelane. JPC-141 potently inhibited (Ki = 52 nM) [3 H]dopamine uptake by VMAT2 in striatal vesicles with 50 to 250-fold greater selectivity for VMAT2 over dopamine, norepinephrine and serotonin plasmalemma transporters. Also, JPC-141 was 57-fold more selective for inhibiting VMAT2 over [3 H]dofetilide binding to hERG channels expressed by HEK293, suggesting relatively low potential for cardiotoxicity...
April 3, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38565090/igfbp5-promotes-neuronal-apoptosis-in-a-6-ohda-toxicant-model-of-parkinson-s-disease-by-inhibiting-the-sonic-hedgehog-signalling-pathway
#7
JOURNAL ARTICLE
Shenglong Guo, Qi Lei, Qian Yang, Ruili Chen
INTRODUCTION: Parkinson's disease (PD) is a most common neurodegenerative disease worldwide. Studies have shown that insulin-like growth factor-binding protein 5 (IGFBP5) may contribute to methamphetamine-induced neurotoxicity and neuronal apoptosis in PC-12 cells and rat striatum. Here, we studied the expression and role of IGFBP5 in the 6-OHDA-toxicant model of PD. METHODS: PC-12 and SH-SY5Y cells were exposed to 50 μM 6-OHDA for 24 h. qRT-PCR, western blotting, CCK-8 assay, EdU staining, annexin V staining, and immunofluorescence were performed to study the effects of IGFBP5 specific siRNAs...
April 2, 2024: Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centre
https://read.qxmd.com/read/38563864/dpp-4-inhibitors-sitagliptin-and-pf-00734-200-mitigate-dopaminergic-neurodegeneration-neuroinflammation-and-behavioral-impairment-in-the-rat-6-ohda-model-of-parkinson-s-disease
#8
JOURNAL ARTICLE
Seong-Jin Yu, Yun Wang, Hui Shen, Eun-Kyung Bae, Yazhou Li, Kumar Sambamurti, Michael A Tones, Margaret M Zaleska, Barry J Hoffer, Nigel H Greig
Epidemiological studies report an elevated risk of Parkinson's disease (PD) in patients with type 2 diabetes mellitus (T2DM) that is mitigated in those prescribed dipeptidyl peptidase 4 (DPP-4) inhibitors. With an objective to characterize clinically translatable doses of DPP-4 inhibitors (gliptins) in a well-characterized PD rodent model, sitagliptin, PF-00734,200 or vehicle were orally administered to rats initiated either 7-days before or 7-days after unilateral medial forebrain bundle 6-hydroxydopamine (6-OHDA) lesioning...
April 2, 2024: GeroScience
https://read.qxmd.com/read/38558302/anti-manic-effect-of-deep-brain-stimulation-of-the-ventral-tegmental-area-in-an-animal-model-of-mania-induced-by-methamphetamine
#9
JOURNAL ARTICLE
Roger B Varela, Suelen L Boschen, Nathanael Yates, Tristan Houghton, Charles D Blaha, Kendall H Lee, Kevin E Bennet, Abbas Z Kouzani, Michael Berk, João Quevedo, Samira S Valvassori, Susannah J Tye
BACKGROUND: Treatment of refractory bipolar disorder (BD) is extremely challenging. Deep brain stimulation (DBS) holds promise as an effective treatment intervention. However, we still understand very little about the mechanisms of DBS and its application on BD. AIM: The present study aimed to investigate the behavioural and neurochemical effects of ventral tegmental area (VTA) DBS in an animal model of mania induced by methamphetamine (m-amph). METHODS: Wistar rats were given 14 days of m-amph injections, and on the last day, animals were submitted to 20 min of VTA DBS in two different patterns: intermittent low-frequency stimulation (LFS) or continuous high-frequency stimulation (HFS)...
April 1, 2024: Bipolar Disorders
https://read.qxmd.com/read/38548247/methamphetamine-increases-risky-choice-in-rats-but-only-when-magnitude-and-probability-of-reinforcement-are-manipulated-within-a-session
#10
JOURNAL ARTICLE
Justin R Yates, Shreeukta Adhikari, Rayah E Bako, Kevin L Berling, Maria R Broderick, Reuben Mains, Bradley Zwick
Risky choice is associated with maladaptive behaviors, particularly substance use disorders. Current animal models of risky choice are often confounded by other constructs like behavioral flexibility and suboptimal choice. The purpose of the current experiment was to determine if the psychostimulant methamphetamine, a drug whose popularity has increased in recent years, increases risky choice in an equivalent expected value (EEV) task. In the EEV task, rats are given a choice between two reinforcer alternatives that differ in magnitude and probability of delivery, but have equivalent expected value...
March 26, 2024: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/38547851/timing-of-methamphetamine-exposure-during-adolescence-differentially-influences-parvalbumin-and-perineuronal-net-immunoreactivity-in-the-medial-prefrontal-cortex-of-female-but-not-male-rats
#11
JOURNAL ARTICLE
Amara S Brinks, Lauren K Carrica, Dominic J Tagler, Joshua M Gulley, Janice M Juraska
INTRODUCTION: Adolescence involves significant reorganization within the medial prefrontal cortex (mPFC), including modifications to inhibitory neurotransmission that may be mediated through parvalbumin (PV) interneurons and their surrounding perineuronal nets (PNNs). These developmental changes, which can result in increased PV neuron activity in adulthood, may be disrupted by drug use resulting in lasting changes in mPFC function and behavior. Methamphetamine (METH), which is a readily available drug used by some adolescents, increases PV neuron activity and could influence the activity-dependent maturational process of these neurons...
March 28, 2024: Developmental Neuroscience
https://read.qxmd.com/read/38539646/impacts-of-self-administered-3-4-methylenedioxypyrovalerone-mdpv-alone-and-in-combination-with-caffeine-on-recognition-memory-and-striatal-monoamine-neurochemistry-in-male-sprague-dawley-rats-comparisons-with-methamphetamine-and-cocaine
#12
JOURNAL ARTICLE
Robert W Seaman, Kariann Lamon, Nicholas Whitton, Brian Latimer, Agnieszka Sulima, Kenner C Rice, Kevin S Murnane, Gregory T Collins
Recent data suggest that 3,4-methylenedioxypyrovalerone (MDPV) has neurotoxic effects; however, the cognitive and neurochemical consequences of MDPV self-administration remain largely unexplored. Furthermore, despite the fact that drug preparations that contain MDPV often also contain caffeine, little is known regarding the toxic effects produced by the co-use of these two stimulants. The current study investigated the degree to which self-administered MDPV or a mixture of MDPV+caffeine can produce deficits in recognition memory and alter neurochemistry relative to prototypical stimulants...
March 6, 2024: Brain Sciences
https://read.qxmd.com/read/38518271/psychedelic-therapy-a-primer-for-primary-care-clinicians-3-4-methylenedioxy-methamphetamine-mdma
#13
JOURNAL ARTICLE
Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: After becoming notorious for its use as a party drug in the 1980s, 3,4-methylenedioxy-methampetamine (MDMA), also known by its street names "molly" and "ecstasy," has emerged as a powerful treatment for post-traumatic stress disorder (PTSD). AREAS OF UNCERTAINTY: There are extensive data about the risk profile of MDMA. However, the literature is significantly biased. Animal models demonstrating neurotoxic or adverse effects used doses well beyond the range that would be expected in humans (up to 40 mg/kg in rats compared with roughly 1-2 mg/kg in humans)...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38486472/sexual-effects-of-commonly-used-recreational-psychostimulants-in-women-and-the-female-rat-model
#14
JOURNAL ARTICLE
Maggie N Mott, Nicholas E Goeders
INTRODUCTION: Recreational psychostimulants have been associated with increased sexual activity or changes in sexual function in women, but every drug in this class has not shown consistent sexual effects in scientific studies. Further, some studies in female animal models may recapitulate the effects observed in humans, while others produce conflicting results. Overall, though, published studies on the sexual effects of recreational stimulants in women are lacking. OBJECTIVES: The objective of this manuscript was to review the published sexual effects of prominent recreational psychostimulants in women and in the female rat model...
March 14, 2024: Sexual Medicine Reviews
https://read.qxmd.com/read/38467490/structural-and-functional-perspectives-on-interactions-between-synthetic-cathinones-and-monoamine-transporters
#15
JOURNAL ARTICLE
Vy T Nguyen, Alan C Harris, Jose M Eltit
Synthetic cathinone derivatives comprise a family of psychoactive compounds structurally related to amphetamine. Over the last decade, clandestine chemists have synthesized a consistent stream of innovative cathinone derivatives to outpace governmental regulatory restrictions. Many of these unregulated substances are produced and distributed as designer drugs. Two of the principal chemical scaffolds exploited to expand the synthetic cathinone family are methcathinone and α-pyrrolidinopentiophenone (or α-pyrrolidinovalerophenone, α-PVP)...
2024: Advances in Pharmacology
https://read.qxmd.com/read/38467479/the-role-of-sex-and-drug-use-during-adolescence-in-determining-the-risk-for-adverse-consequences-of-amphetamines
#16
JOURNAL ARTICLE
Lauren K Carrica, Joshua M Gulley
Use of amphetamines during adolescence, a critical period of brain development and reorganization, may lead to particularly adverse outcomes that are long-lasting. Similarly, female users may be uniquely vulnerable to certain aspects of drug use. A recognition of the role of use during adolescence and sex on outcomes of amphetamine and methamphetamine exposure are of critical importance in understanding and treating substance use disorders. This chapter highlights what human research, which has been largely epidemiological, suggests about sex and age differences in drug use patterns and outcomes...
2024: Advances in Pharmacology
https://read.qxmd.com/read/38464016/timing-of-methamphetamine-exposure-during-adolescence-differentially-influences-parvalbumin-and-perineuronal-net-immunoreactivity-in-the-medial-prefrontal-cortex-of-female-but-not-male-rats
#17
Amara S Brinks, Lauren K Carrica, Dominic J Tagler, Joshua M Gulley, Janice M Juraska
Adolescence involves significant reorganization within the medial prefrontal cortex (mPFC), including modifications to inhibitory neurotransmission mediated through parvalbumin (PV) interneurons and their surrounding perineuronal nets (PNNs). These developmental changes, which result in increased PV neuron activity in adulthood, may be disrupted by drug use resulting in lasting changes in mPFC function and behavior. Methamphetamine (METH), which is a readily available drug used by some adolescents, increases PV neuron activity and could influence the activity-dependent maturational process of these neurons...
February 28, 2024: bioRxiv
https://read.qxmd.com/read/38428165/the-role-of-orexin-receptors-within-the-ca1-area-in-the-acquisition-and-expression-of-methamphetamine-place-preference
#18
JOURNAL ARTICLE
Fazel Moshrefi, Amir Mohammad Farrokhi, Mojdeh Fattahi, Ronak Azizbeigi, Abbas Haghparast
Treatment of Methamphetamine (METH) use disorder has become a crucial public health issue. The orexin system manipulation has provided promising evidence to attenuate addictive-like behaviors. This study explored the role of the orexin 1 receptor and orexin 2 receptor (OX1R and OX2R) in the CA1 area of the hippocampal formation in the acquisition and expression of METH-induced place preference. Animals were subjected to bilateral administration of different dosages (1, 3, 10, and 30 nmol/0.5 μl DMSO per side) of a selective OX1R antagonist, SB334867, or selective OX2R antagonist, TCS OX2 29 into the CA1 area throughout the conditioning phase or once on the post-conditioning phase in separate control and experimental groups...
February 26, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38357285/multivalent-vaccination-strategies-protect-against-exposure-to-polydrug-opioid-and-stimulant-mixtures-in-mice-and-rats
#19
JOURNAL ARTICLE
Daihyun Song, Bethany Crouse, Jennifer Vigliaturo, Mariah M Wu, Dagny Heimisdottir, Andrew J Kassick, Saadyah E Averick, Michael D Raleigh, Marco Pravetoni
Illicit drug mixtures containing opioids and stimulants have been responsible for the majority of fatal drug overdoses among occasional users, and those with either opioid use disorder (OUD) or substance use disorder (SUD). As a complementary strategy to current pharmacotherapies, active immunization with conjugate vaccines has been proposed as a viable intervention to treat OUD as well as other SUD for which there are either limited or no treatment options. Vaccination against opioids and stimulants could help address the limitations of current medications (e...
February 9, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38355360/focused-ultrasound-stimulation-of-infralimbic-cortex-attenuates-reinstatement-of-methamphetamine-induced-conditioned-place-preference-in-rats
#20
JOURNAL ARTICLE
Chia-Wei Lin, Min-Hsuan Cheng, Ching-Hsiang Fan, Hwei-Hsien Chen, Chih-Kuang Yeh
Methamphetamine (MA) use disorder poses significant challenges to both the affected individuals and society. Current non-drug therapies like transcranial direct-current stimulation and transcranial magnetic stimulation have limitations due to their invasive nature and limited reach to deeper brain areas. Transcranial focused ultrasound (FUS) is gaining attention as a noninvasive option with precise spatial targeting, able to affect deeper areas of the brain. This research focused on assessing the effectiveness of FUS in influencing the infralimbic cortex (IL) to prevent the recurrence of MA-seeking behavior, using the conditioned place preference (CPP) method in rats...
February 13, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
keyword
keyword
7567
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.